Development of the implantable transvenous cardioverter

Douglas P. Zipes, James J. Heger, William M. Miles, Eric N. Prystowsky

Research output: Contribution to journalArticle

Abstract

The development of the transvenous cardioverter, from the initial animal studies, to the clinical studies using temporary leads, to the initial permanent implants is described. Shocks ≤2.0 joules synchronized to the QRS complex and delivered through a specially designed catheter electrode placed in the apex of the right ventricle successfully terminate most episodes of ventricular tachycardia in patients. The implanted unit which also serves as a demand ventricular pacemaker, can be used to perform programmed electrophysiologic studies. Future devices must be capable of defibrillation and more accurate arrhythmia detection.

Original languageEnglish (US)
Pages (from-to)67D-72D
JournalThe American journal of cardiology
Volume54
Issue number9
DOIs
StatePublished - 1984

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Development of the implantable transvenous cardioverter'. Together they form a unique fingerprint.

  • Cite this

    Zipes, D. P., Heger, J. J., Miles, W. M., & Prystowsky, E. N. (1984). Development of the implantable transvenous cardioverter. The American journal of cardiology, 54(9), 67D-72D. https://doi.org/10.1016/S0002-9149(84)80289-1